CYP2B6 polymorphism and nonnucleoside reverse transcriptase inhibitor plasma concentrations in Chinese HIV-infected patients.
about
Effect of CYP2B6 Gene Polymorphisms on Efavirenz Plasma Concentrations in Chinese Patients with HIV InfectionMeasuring the overall genetic component of nevirapine pharmacokinetics and the role of selected polymorphisms: towards addressing the missing heritability in pharmacogenetic phenotypes?ABCB1 variation and treatment response in AIDS patients: initial results of the Henan cohortPopulation pharmacokinetic/pharmacogenetic model for optimization of efavirenz therapy in Caucasian HIV-infected patients.Worldwide variation in human drug-metabolism enzyme genes CYP2B6 and UGT2B7: implications for HIV/AIDS treatment.Individualization of antiretroviral therapy.Pharmacogenetic markers of CYP2B6 associated with efavirenz plasma concentrations in HIV-1 infected Thai adults.Impact of pharmacogenetic markers of CYP2B6, clinical factors, and drug-drug interaction on efavirenz concentrations in HIV/tuberculosis-coinfected patients.Antiretroviral drugs in pediatric HIV-infected patients: pharmacokinetic and practical challenges.The effect of ABCB1 genetic variants on chemotherapy response in HIV and cancer treatment.Pharmacogenetics of antiretroviral therapy.Genetic Polymorphisms Affecting the Pharmacokinetics of Antiretroviral Drugs.Increased MMAB level in mitochondria as a novel biomarker of hepatotoxicity induced by Efavirenz.Distinctiveness of the Roma population within CYP2B6 worldwide variation.
P2860
Q28548638-26E44905-D42F-48FB-ADF3-7766CB9FC23CQ33720712-741B40DF-6614-4AC7-89B0-5966115B2561Q34571645-75C57176-4958-4498-8D7D-AD6AED0A4359Q35364120-21C1CF8A-32F8-4773-A8D0-089F16A8F63CQ36079108-ED62D0A9-055E-4C10-91B8-3A1506EE64A5Q36441423-44D85FEF-56FA-400D-91A7-0CA86CE8C7CDQ36468146-A9C1641C-606F-4611-BFC6-885829C3A33DQ36558327-97E83F0E-B46C-40BC-B232-EDFBE782F12EQ37866289-7C916B65-3820-4646-86FB-8C6BC3E6AFA3Q37946959-65A8207B-DA98-4B74-AABE-4C4AD52655C2Q38221179-229068B9-F6E6-4E4B-8E2D-A010A073998BQ38957969-2A94D510-11FB-44AE-908C-54E444203E75Q46250998-00D69E40-A28B-4EE3-83EF-74F519A5F947Q47670434-8E8F1E41-F856-469E-B665-AFD2746C2B4E
P2860
CYP2B6 polymorphism and nonnucleoside reverse transcriptase inhibitor plasma concentrations in Chinese HIV-infected patients.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
CYP2B6 polymorphism and nonnuc ...... Chinese HIV-infected patients.
@en
CYP2B6 polymorphism and nonnuc ...... Chinese HIV-infected patients.
@nl
type
label
CYP2B6 polymorphism and nonnuc ...... Chinese HIV-infected patients.
@en
CYP2B6 polymorphism and nonnuc ...... Chinese HIV-infected patients.
@nl
prefLabel
CYP2B6 polymorphism and nonnuc ...... Chinese HIV-infected patients.
@en
CYP2B6 polymorphism and nonnuc ...... Chinese HIV-infected patients.
@nl
P2093
P1476
CYP2B6 polymorphism and nonnuc ...... Chinese HIV-infected patients.
@en
P2093
Hongzhou Lu
Jianjun Sun
Lijun Zhang
Yaming Yao
Zhenyan Wang
P304
P356
10.1097/FTD.0B013E3181EA953C
P577
2010-10-01T00:00:00Z